Deep Venous Thrombosis Clinical Trial
Official title:
Intermittent Pneumatic Compression in the Lower Limbs: Systemic and Local Effects in Coagulation Status, Microcirculation, Tissue Metabolic Activity and Collagen Production.
This study aims to compare two different external calf compression devices applied in healthy individuals. These devices are commonly used in medical care in order to prevent the formation of blood clots, for example during immobilization after surgery. We aim to confirm the effects of external cyclic compression on healing and blood clotting and also to identify the one which is more effective.
Aims: 1. To confirm that IPC (intermittent pneumatic compression) has a positive effect on systemic coagulation status, tissue metabolic activity, collagen formation and tissue microcirculation. 2. To compare the above effect of two different IPC devices: one rapid calf-IPC which expels blood from the veins sharp and rapidly and one slow calf-IPC, which pumps the blood in a more gentle and progressive way. This study could also make implications on how the blood flow parameters could be interpreted in the clinical setting, as previous haemodynamic studies have explained the superiority of the rapid device in terms of peak velocity and the superiority of the slow device in terms of total ejected volume per individual stimulus. Materials and Methods: 10-15 healthy individuals are planned to be recruited. The subjects will be lying in a prone position. A cuff connected with a Calf-IPC device will be wrapped around each calf and will be functioning for 120 minutes. Microdialysis catheters will be inserted with the tips about 1 mm from the volar side of each Achilles tendon. In addition, one adhesive sensor will be applied on each calf just distal to the lower part of the cuff, in order to measure tissue oxygen mixed saturation (INVOS). Blood samples will be taken via a venous catheter in antecubital fossa just before the application of the IPC, and at 30, 60 and 120 minutes. From the serum, several systemic coagulation factors will be measured (tissue plasminogen activator (tPA), plasminogen activator inhibitor type 1 (PAI), tissue factor pathway inhibitor (TFPI), D-dimer, von Willebrand factor and factor VIIa). From the microdialysis diffusate , two groups of substances will be measured: a) metabolites, such as pyruvate and b) collagen macromolecules, such as procollagen type I and III. The ultimate goal is to assess the role of different IPC patterns on deep venous thrombosis prevention and promotion of tissue healing. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05171075 -
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
|
Phase 3 | |
| Completed |
NCT02889562 -
Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation
|
Phase 2/Phase 3 | |
| Completed |
NCT01333618 -
Introducer Curving Technique for Tilt of Transfemoral Günther Tulip Inferior Vena Cava Filter
|
N/A | |
| Completed |
NCT00812370 -
The UNBLOCK Study: Utilization of Bivalirudin On Clots in Kids
|
Phase 1 | |
| Completed |
NCT02552420 -
The Clinical Application of Infrared Thermal Imaging Detecting Venous Thromboembolism
|
Phase 2/Phase 3 | |
| Completed |
NCT00178789 -
Sonography Outcomes Assessment Program for Lower Extremity Deep Venous Thrombosis
|
Phase 1/Phase 2 | |
| Completed |
NCT03251963 -
Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients
|
Phase 2 | |
| Completed |
NCT03286985 -
The Prevalence and Incidence of DVT in General ICU
|
||
| Completed |
NCT04414332 -
Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry
|
||
| Completed |
NCT02211326 -
Genotype-guided Warfarin Individualized Treatment
|
N/A | |
| Completed |
NCT03296280 -
Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
|
||
| Recruiting |
NCT03937583 -
Screening for Cancer in Patients With Unprovoked VTE
|
Phase 4 | |
| Completed |
NCT00628576 -
Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities
|
Phase 3 | |
| Completed |
NCT04979026 -
Clinical Investigation of a Novel Approach for the Prevention of Deep Venous Thrombosis After Total Knee Replacement
|
N/A | |
| Active, not recruiting |
NCT02318472 -
Early Mobilization After Achilles Tendon Rupture
|
N/A | |
| Completed |
NCT01221805 -
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
|
Phase 4 | |
| Recruiting |
NCT03740633 -
Functional Training for the Prevention of Deep Venous Thrombosis
|
Phase 3 | |
| Completed |
NCT03707665 -
Deep Venous Thrombosis Screening in the ICU by Nurses
|
||
| Recruiting |
NCT05171049 -
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
|
Phase 3 | |
| Completed |
NCT01542723 -
Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy
|
N/A |